Wedbush Cuts Price Target on Cadence Pharma (CADX), Tweaks Estimates on OFIRMEV Vial Sales
Go back to Wedbush Cuts Price Target on Cadence Pharma (CADX), Tweaks Estimates on OFIRMEV Vial Sales| Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) | Delayed: 13.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.98 | 52 Week High | $11.92 | |||
| Open | $13.98 | 52 Week Low | $4.45 | |||
| Day High | $13.98 | P/E | N/A | |||
| Day Low | $13.98 | EPS | $-0.49 | |||
| Volume | 282,940 | |||||
